Microvast Holdings, Inc. (NASDAQ:MVST - Get Free Report)'s stock price traded up 7.3% during mid-day trading on Friday . The stock traded as high as $2.17 and last traded at $2.14. 3,259,721 shares were traded during trading, a decline of 77% from the average session volume of 14,186,474 shares. The stock had previously closed at $1.99.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reiterated a "buy" rating and set a $3.00 price target on shares of Microvast in a report on Monday, November 18th.
Check Out Our Latest Analysis on MVST
Microvast Stock Up 9.5 %
The firm has a market cap of $705.93 million, a price-to-earnings ratio of -5.74 and a beta of 2.14. The firm has a 50-day moving average of $1.59 and a two-hundred day moving average of $0.75. The company has a current ratio of 1.30, a quick ratio of 0.83 and a debt-to-equity ratio of 0.24.
Institutional Trading of Microvast
A number of hedge funds have recently modified their holdings of the company. Renaissance Technologies LLC acquired a new stake in Microvast during the second quarter valued at approximately $90,000. XTX Topco Ltd acquired a new stake in Microvast during the 2nd quarter valued at $80,000. Point72 DIFC Ltd bought a new stake in shares of Microvast during the second quarter worth $28,000. Cubist Systematic Strategies LLC acquired a new stake in shares of Microvast in the second quarter valued at $264,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in Microvast in the 2nd quarter valued at about $141,000. Institutional investors own 20.72% of the company's stock.
Microvast Company Profile
(
Get Free Report)
Microvast Holdings, Inc provides battery technologies for electric vehicles and energy storage solutions. The company offers a range of cell chemistries, such as lithium titanate oxide, lithium iron phosphate, and nickel manganese cobalt version 1 and 2. It also designs, develops, and manufactures battery components, such as cathode, anode, electrolyte, and separator.
Featured Stories
Before you consider Microvast, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microvast wasn't on the list.
While Microvast currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
